The Food and Drug Administration recently approved Aurobindo Pharma's anti-infective linezolid injection.
Linezolid — a generic form of Pharmacia & Upjohn's brand name Zyvox injection — is intended to treat infections caused by susceptible Gram-positive bacteria.
The newly approved drug has an estimated market value of $87 million for the 12 months ending in June 2016.
India-based Aurobindo Pharma expects to launch the product by the end of the second quarter. The linezolid injection marks the drugmaker's 275th FDA approval.
More articles on the drug market:
AbbVie sues Amgen for patent infringement on Humira: 5 things to know
Bristol-Myers stock dips 18% following failed trial
Drug company drives $48k brain-eating amoeba treatment to SC hospital